Howard Lossing

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland.

Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland.

Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland.

Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland.

Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA.

Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland.

Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland.